The highly invasive behavior of glioblastoma cells contributes to the morbidity and mortality associated with these tumors. The integrin-mediated adhesion and migration of glioblastoma cells on brain matrix proteins is enhanced by stimulation with growth factors, including platelet-derived growth factor (PDGF). As focal adhesion kinase (FAK), a nonreceptor cytoplasmic tyrosine kinase, has been shown to promote cell migration in various other cell types, we analysed its role in glioblastoma cell migration. Forced overexpression of FAK in serumstarved glioblastoma cells plated on recombinant (rec)-osteopontin resulted in a twofold enhancement of basal migration and a ninefold enhancement of PDGF-BBstimulated migration. Both expression of mutant FAK(397F) and the downregulation of FAK with small interfering (si) RNA inhibited basal and PDGF-stimulated migration. FAK overexpression and PDGF stimulation was found to increase the phosphorylation of the Crk-associated substrate (CAS) family member human enhancer of filamentation 1 (HEF1), but not p130CAS or Src-interacting protein (Sin)/Efs, although the levels of expression of these proteins was similar. Moreover downregulation of HEF1 with siRNA, but not p130CAS, inhibited basal and PDGF-stimulated migration. The phosphorylated HEF1 colocalized with vinculin and was associated almost exclusively with 0.1% Triton X-100 insoluble material, consistent with its signaling at focal adhesions. FAK overexpression promoted invasion through normal brain homogenate and siHEF1 inhibited this invasion. Results presented here suggest that HEF1 acts as a necessary and specific downstream effector of FAK in the invasive behavior of glioblastoma cells and may be an effective target for treatment of these tumors.
Introduction
The high levels of morbidity and mortality associated with glioblastoma tumors is due in part to their highly invasive behavior (Merlo and Bettler, 2004) . The integrin-mediated adhesion and migration of the glioblastoma cells on brain matrix proteins is enhanced by stimulation with growth factors, including plateletderived growth factor (PDGF) and epidermal growth factor (EGF). As activation of focal adhesion kinase (FAK), a nonreceptor cytoplasmic tyrosine kinase, promotes cell migration in various types of cells (reviewed in Schlaepfer and Mitra, 2004) , its potential role in the migration of glioblastoma tumors is of considerable interest. We and others have shown that FAK protein expression and activity are elevated in Grade III (anaplastic astrocytoma) and Grade IV (glioblastoma) malignant astrocytoma tumors (Zagzag et al., 2000; Hecker et al., 2002) . We also have shown that forced overexpression of FAK in U-251MG glioblastoma cells promotes haptotactic migration (Wang et al., 2000) . In addition, Jones et al. (2001) have shown that expression of a dominant interfering form of FAK in T98 glioblastoma cells inhibits EGFstimulated migration.
Integrin-mediated cell adhesion is thought to trigger conformational changes in FAK that affect its ability to bind several key molecules, including membrane proteins, such as the PDGF receptor (PDGFr), the EGF receptor (EGFR) (Sieg et al., 2000) , and cellular Src (Schaller et al., 1994 Calalb et al., 1995) . The latter is thought to be due to a conformational change that results in autophosphorylation of FAK at Y397 (Cooper et al., 2003) , which also permits cellular Src phosphorylation of FAK, thereby promoting FAK activity. In addition, the interaction of cellular Src with FAK promotes cellular Src phosphorylation of the Crkassociated substrate (CAS) proteins Nakamoto et al., 1996 . CAS proteins are phosphorylated by cellular Src and FAK upon integrin-mediated cell adhesion (Sakai et al., 1994; Vuori et al., 1996; Tachibana et al., 1997) and phosphorylation of CAS proteins results in the recruitment of a Crk family adaptor molecule, and the activation of a small GTPase (Rac1 or Cdc42) and JNK, which promote cell migration (Dolfi et al., 1998; Kiyokawa et al., 1998; Klemke et al., 1998) . Although there is considerable domain homology among the three known members of the CAS family, p130CAS (Sakai et al., 1994) , human enhancer of filamentation 1 (HEF1) (Law et al., 1996) , and Src-interacting protein (Sin)/ embryonic Fyn substrate (Efs) (Ishino et al., 1995) , their expression, utilization, and function differ (Law et al., 1996 (Law et al., , 2000 Manie et al., 1997; Almeida et al., 2000; Cho and Klemke, 2000; Fashena et al., 2002) .
Little is known regarding the potential role of CAS proteins in PDGF signaling, despite their known association with FAK. We therefore investigated the possibility that CAS family members act as downstream effectors of FAK in the promotion of glioblastoma cell migration and invasion. We show here that HEF1, rather than p130CAS or Sin/Efs, is necessary for basal and PDGF-stimulated migration of glioblastoma cells adherent to recombinant (rec)-osteopontin or vitronectin.
Results

FAK promotes PDGF-stimulated migration of glioblastoma cells adherent to rec-osteopontin or vitronectin
The PDGF-stimulated migration of glioblastoma cells on osteopontin and vitronectin is of interest as the PDGF A and B genes, as well as the PDGFr-a and -b genes, are upregulated in glioblastoma tumors (Hermanson et al., 1992) , osteopontin and vitronectin are expressed in glioblastoma tumors, and osteopontin is also expressed in the normal brain (Gladson et al., 1995; Ding et al., 2002) . We therefore analysed the role of FAK in the migration of glioblastoma cells using previously described clones of U-251MG glioblastoma cells that overexpress wild-type FAK (clone OFAK5) under the regulation of a TET-inducible promoter (Wang et al., 2000) . Under serum-starving conditions, the induction of FAK in the OFAK5 clones was estimated to be threefold, as determined by densitometric analysis of anti-FAK IgG immunoblots ( Figure 1a ) using antibodies to vinculin and actin as loading controls.
Migration was analysed using a scratch assay. PDGF stimulation resulted in a twofold enhancement of migration of vehicle-treated OFAK5 cells into the scratched area and doxycycline-induced overexpression of FAK in the OFAK5 cells resulted in a ninefold enhancement of migration (Figure 1b and c) . Similar results were obtained on PDGF stimulation of OFAK5 cells plated onto vitronectin (data not shown). The possibility that the enhanced migration of the PDGFstimulated OFAK5 cells on rec-osteopontin was due to enhancement of cell proliferation was ruled out by the failure of mitomycin C to significantly affect PDGFstimulated migration of either doxycycline-or vehicletreated OFAK5 cells (data not shown). As glioblastomas are a heterogeneous group of tumors, we analysed the effects of PDGF on a second glioblastoma cell line, U-87MG, and found a fivefold increase in migration on PDGF stimulation of U-87MG cells adherent to rec-osteopontin (Figure 1d) .
To examine the effects of downregulation of FAK two approaches were used. In the first previously described (Hecker et al., 2004) U-251MG glioblastoma cells stably expressing a dominant-negative mutant FAK(397F) construct (OFAK397F-18 cells) under the regulation of a Tet-inducible promoter (Figure 2a ) exhibited a significant reduction in both basal and PDGF-stimulated migration on rec-osteopontin (Figure 2b ). In the second, a small interfering (si) RNA approach was used to downregulate FAK in U-87MG cells, using downregulation of another FAK family member, Pyk2, as a control. In this case, the effects of siRNA treatment on migration were analysed using cells adherent to vitronectin as serum starvation together with liposome transfections adversely affected cell attachment to rec-osteopontin. The efficacy of the siRNA treatment in reducing protein levels (>70%) (Figure 2c and d), without affecting cell morphology or viability was confirmed. Downregulation of FAK significantly inhibited both basal (70%) and PDGF-stimulated (90%) migration of serum-starved U-87MG cells adherent to vitronectin (Figure 2e ). The downregulation of Pyk2 had no effect on basal migration, but inhibited in part the PDGF-stimulated migration (40% inhibition) (Figure 2e ).
FAK overexpression and PDGF stimulation promote phosphorylation of HEF1, but not p130CAS or Sin/Efs, in glioblastoma cells adherent to rec-osteopontin or vitronectin We next examined the interactions of FAK with members of the CAS family of docking proteins in glioblastoma cells. These interactions of FAK with CAS family members appear to be cell-type specific with FAK overexpression promoting phosphorylation of p130CAS in fibroblasts, CHO cells and COS cells (Cary et al., 1998; Klemke et al., 1998) , and HEF1 in T cells (van Seventer et al., 2001) . PDGF-stimulated FAK phosphorylation in U-251MG cells plated onto vitronectin as we have reported previously (Figure 3a , lanes 1 and 2) and enhanced phosphorylation of HEF1 (Figure 3a , lanes 5 and 6), whereas p130CAS phosphorylation was minimal both in the presence and absence of PDGF stimulation (Figure 3a, lanes 3 and 4) . Analysis of the OFAK5 cells, which are derived from U-251MG cells, plated onto rec-osteopontin, indicated that forced overexpression of FAK increased the basal phosphorylation of HEF1 by twofold (Figure 3b , lanes 1 and 2), and that PDGF stimulation resulted in a further E2-fold enhancement (Figure 3b, lanes 2 and 3) . This PDGF-stimulated phosphorylation of HEF1 was transient, and had declined by 10 min post-PDGF stimulation (Figure 3b, lanes 3 and 4) . Phosphorylation of p130CAS or Sin/Efs was not observed whether or not FAK was overexpressed or the cells stimulated with PDGF ( Figure 3b ). As the relative levels of expression of p130CAS, HEF1, and Sin/Efs in the glioblastoma cells could affect their utilization, we estimated the expression of these molecules in cell lysates by Western Migration of glioblastoma cells M Natarajan et al blotting with polyclonal antibodies. Assuming these antibodies are of similar affinity, no significant difference in the levels of p130CAS, HEF1, and Sin/Efs proteins were observed (Figure 3c ). Similarly, HEF1 phosphorylation was increased 2.5-fold on PDGF stimulation of U-87MG cells adherent to vitronectin, and phosphorylation of p130CAS or Sin/ Efs was not observed (Figure 3d ), although the expression of all three proteins was similar in these cells (Figure 3e ). Thus, HEF1 appears to be the specific downstream effector of FAK in serum-starved glioblastoma cells adherent to rec-osteopontin or vitronectin.
FAK promotes invasion of glioblastoma cells through detergent-free normal brain homogenate
The potential clinical significance of these experiments was tested by analysis of the invasive behavior of the cells. FAK overexpression has been shown to promote invasion of A549 lung adenocarcinoma cells and of v-Src-transformed fibroblasts through Matrigel (Sieg et al., 2000; Brabek et al., 2004) . Using an invasion assay into detergent-free normal brain homogenate as we have described previously (Ding et al., 2002) , we found a twofold increase in invasion of doxycyclinetreated OFAK5 cells as compared to cells administered Figure 1 FAK promotes PDGF-stimulated migration of glioblastoma cells adherent to rec-osteopontin. OFAK5 cells were treated with 2 mg/ml doxycycline or vehicle for 2 days in DMEM-10% FBS, replated onto rec-osteopontin in DMEM-0.4% FBS-1% BSA, and treated with 1 mg/ml doxycycline or vehicle for 2 days. (a) RIPA lysates were subjected to SDS-PAGE and immunoblotted with the indicated antibodies. (b-c), Monolayers (371C, 5% CO 2 ) of OFAK5 cells treated as described above were scratched, photographed, stimulated with PDGF (332 pM) or vehicle (10 min), washed, and rephotographed after 48 h. Cells in five fields in the scratched area (200 Â 500 mm 2 area) were counted. The conditions were assayed in replicas of three, the results from two experiments combined and presented here as the mean7s.e.m. (d) Serum-starved (48 h) U-87MG cells were similarly plated onto rec-osteopontin-coated wells, stimulated with PDGF or vehicle and subject to the scratch assay. (48 h) U-251MG cells were plated onto rec-osteopontin or vitronectin-coated wells in serum-free DMEM-1% BSA for 3 h (371C, 5% CO s ), stimulated (10 min) with PDGF (83 pM) or vehicle, lysed in RIPA lysis buffer, and 300 mg of lysate immunoprecipitated with the indicated antibodies, followed by SDS-PAGE and immunoblotting with the indicated antibodies. (b) OFAK5 cells as described in Figure 1 were stimulated with PDGF (332 pM) or vehicle (3 or 10 min), washed, lysed in RIPA lysis buffer, and 300 mg of lysate immunoprecipitated with the indicated antibody, followed by SDS-PAGE and immunoblotting with the indicated antibodies. (c) U-251MG treated as described in (a) were lysed, and 40 mg of lysate from each sample subjected to SDS-PAGE, followed by immunoblotting with the indicated antibodies. Serum-starved (48 h) U-87MG cells plated onto vitronectin-coated flasks in DMEM-1% BSA were stimulated with PDGF (332 pM) or vehicle (3 or 10 min), washed, lysed, and in (d), immunoprecipitated with the indicated antibodies, subjected to SDS-PAGE and blotted with the indicated antibodies or in (e), 40 mg of lysate from each sample subjected to SDS-PAGE, followed by immunoblotting with the indicated antibodies.
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vehicle (P ¼ 0.009) (Figure 4a ), suggesting that FAK promotes invasion of glioblastoma cells. As p130CAS promotes invasion of v-Src-transformed fibroblasts (Brabek et al., 2004) , we also examined CAS family member phosphorylation in the serum-starved glioblastoma cells adherent to normal brain homogenate. Consistent with a primary role of HEF1, we found a threefold increase in HEF1 phosphorylation on FAK overexpression in the OFAK5 cells, that was further increased (twofold) on PDGF stimulation (Figure 4b ). Barely detectable levels of p130CAS phosphorylation (Figure 4c) , and no phosphorylation of Sin/Efs (Figure 4d ), were observed in the presence and absence of FAK overexpression with or without PDGF stimulation.
Downregulation of HEF1, but not p130CAS, inhibits basal, FAK-promoted and PDGF-stimulated migration, as well as invasion of glioblastoma cells As the above studies implicate FAK-promoted HEF1 phosphorylation in PDGF-stimulated migration and invasion, we examined the requirement for HEF1 in PDGF-stimulated migration and invasion by downregulation of HEF1 with siRNA using downregulation of another CAS family member, sip130CAS, as a control. The effective downregulation of the proteins on siRNA treatment of OFAK5 cells (Figure 5a and b) and U-87MG cells (Figure 5c , the transfection repeated at 24 h, and at 48 h, treatment with doxycycline or vehicle was begun and continued throughout the experiment. At 72 h, the cells were replated onto rec-osteopontin-coated wells in DMEM-0.4% FBS-1% BSA and subject to the scratch assay as described in Figure 1 . (f) U-87MG cells were similarly transfected with siHEF1 or sip130CAS, the cells harvested with buffered EDTA, resuspended in DMEM-0.8% FBS-1% BSA and plated onto vitronectin-coated wells. At 24 h the monolayer was subject to the scratch assay and photographed at 48 h as described in Figure 1 . (g) OFAK5 cells treated as described in Figure 1 were harvested with buffered EDTA, resuspended in DMEM-0.4% FBS-1% BSA, and plated onto 8 mm pore filters coated with 50 mg/ml normal brain homogenate and allowed to invade for 24 h (371C, 5% CO 2 ). Cells on the bottom filter surface were fixed, stained, and counted. The data were analysed and presented as the mean7s.e.m. for each condition. The experiments were repeated twice and a representative experiment is shown. gration, whereas downregulation of p130CAS had no effect (Figure 5f ). Downregulation of HEF1 also significantly inhibited (70%) OFAK5 cell invasion through normal brain homogenates, whereas downregulation of p130CAS had no effect (Figure 5g ).
FAK acts to promote migration through activation of the Rac1 effector molecule and localization of HEF1 to focal adhesions We next explored the effector arm downstream of FAKinduced phosphorylation of HEF1. Rac1 is a small GTPase that promotes membrane protrusion and may therefore contribute to migration (Ridley et al., 1992) . Pull-down assays indicated an approximately twofold elevation in Rac1 activity over basal levels on doxycycline treatment of OFAK5 cells adherent to rec-osteopontin ( Figure 6a, lanes 1 and 2) , and a further elevation on PDGF stimulation for 10 min (Figure 6a , lane 4). Expression of the mutant FAK(397F) significantly inhibited both basal and PDGF-stimulated Rac1 activity ( Figure 6b ). Analysis of the migratory cells in the scratch assays, indicated that Rac1 was localized predominantly to filopodia and lamellipodia (Figure 6c ), supporting its role in promoting membrane protrusion and thereby promoting migration. Moreover, the number of cells with membrane protrusions (filopodia and lamellipodia) was increased E2-fold on stimulation with PDGF, with an E3-fold increase being observed on PDGF stimulation of cells overexpressing FAK (data not shown). FAK localization to focal contacts (early or immature adhesion complexes) or to focal adhesions (mature adhesion complexes) is necessary for its activation and signaling (Shen and Schaller, 1999) . We have reported previously that exogenous wild-type FAK colocalizes with vinculin to focal adhesions in OFAK5 cells overexpressing FAK (Wang et al., 2000) . CAS family members also have been shown to localize to focal contacts or focal adhesions (Harte et al., 1996) . We therefore examined the localization of HEF1 in glioblastoma cells adherent to rec-osteopontin or vitronectin, and found that HEF1 colocalized with the integrin av subunit at focal adhesions in these cells whether or not FAK was overxpressed (Figure 6d and data not shown).
Phosphorylation of HEF1 is necessary for its signaling but a phosphospecific antibody directed toward HEF1 is not available; therefore, we examined the localization of phosphorylated HEF1 by differential solubilization of the membrane fraction that contains bundled actin fibers. We found that the majority of the HEF1 was associated with the insoluble material in OFAK5 cells and that on overexpression of FAK the phosphorylated HEF1 was localized nearly exclusively to the insoluble fraction (Figure 6e, lanes 1-4) . As described above, the PDGF-stimulated HEF1 phosphorylation was transient (Figure 6e, lane 4) . The known association of vinculin with the insoluble material was confirmed and overexpression of FAK did not appear to affect this (Figure 6g, lanes 1 and 2 and 5 and 6 ). The total levels of vinculin and HEF1 protein in the OFAK5 cells were not altered by administration of doxycycline or vehicle, or on PDGF stimulation (Figure 6h-j) .
Discussion
Our data indicate that phosphorylation of HEF1 is critical for FAK-promoted and PDGF-stimulated migration and invasion of glioblastoma cells. When serumstarved glioblastoma cells were adherent to rec-osteopontin, vitronectin, or normal brain homogenate, we found an increase in the phosphorylation of HEF1 on FAK overexpression and PDGF stimulation. Under these assay conditions, phosphorylation of p130CAS and Sin/Efs was absent or minimal.
Although p130CAS is expressed ubiquitously (Sakai et al., 1994) , HEF1 is most abundantly expressed in epithelial and lymphoid cells (Law et al., 1996; Minegishi et al., 1996) and the developing hindbrain (Merrill et al., 2004) , whereas Sin/Efs is expressed in embryonic tissues, the thymus, adult muscle, and brain (Ishino et al., 1995; Alexandropoulos et al., 2003) . However, our finding of relatively similar levels of HEF1, p130CAS, and Sin/Efs protein in the two glioblastoma cell lines, indicates that the specific phosphorylation of HEF1 is not due to the available levels of the CAS family members in the glioblastoma cells. The preferential association of different CAS family members with different cell functions has been indicated previously. For example, the responses to different apoptotic stimuli seem to be affected by the CAS family member activated (Almeida et al., 2000; Cho and Klemke, 2000; Law et al., 2000) .
These studies indicate that FAK plays a key role in glioblastoma cell migration and invasion. Under identical conditions to those used for the phosphorylation studies, we found that overexpression of FAK resulted Figure 1 were lysed, and equivalent amounts of lysate subjected to GST-PBD pull-down, followed by SDS-PAGE and blotting with mAb anti-Rac1. (c) OFAK5 cells treated as described in Figure 1 were fixed, blocked, reacted with mAb anti-Rac1, followed by anti-mouse Alexa 488 IgG, Hoescht and photography of the scratched area. These experiments were repeated twice with similar results. (d) OFAK5 cells treated as described in the legend for Figure 1 were fixed and permeabilized. Cells were then reacted sequentially with 15 mg/ml mAb anti-HEF1, Alexa 488-conjugated anti-mouse IgG, 20 mg/ml rabbit anti-integrin av IgG, Alexa 594-conjugated anti-rabbit IgG, and Hoescht stain, coverslipped, viewed, and photographed on a Nikon laser microscope. (c-d, X2500 mag) . (e-g) OFAK5 cells that had been plated and treated as described in Figure 1 were stimulated with PDGF or vehicle as indicated. The Triton X-100 soluble fraction was obtained by incubating the cell monolayer with 0.1% Triton X-100 in PBS with protease inhibitors for 10 min at 41C, followed by aspiration. The soluble fraction was further solubilized with 2 Â RIPA lysis buffer. The 0.1% Triton X-100 insoluble fraction was then solubilized with RIPA lysis buffer (10 min, 41C). Lysate (300 mg) was immunoprecipitated with the indicated antibody, followed by SDS-PAGE and immunoblotting with the indicated antibodies. (h-j) Lysate (40 mg) was subjected to SDS-PAGE and immunoblotted with the indicated antibodies. These experiments were repeated twice with similar results.
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M Natarajan et al in a dramatic increase in PDGF-stimulated migration and that inhibiton of FAK by expression of a functional mutant FAK(397F) resulted in significant inhibition of PDGF-stimulated migration and also basal migration. The significance of FAK in PDGF-stimulated glioblastoma cell migration was further supported by studies
Migration of glioblastoma cells M Natarajan et al using a second glioblastoma cell line in which downregulation of FAK with siRNA dramatically inhibited the basal and PDGF-stimulated migration, whereas downregulation of Pyk2 only partly inhibited PDGFstimulated migration. Moreover, overexpression of FAK promoted the invasive behavior of the glioblastoma cells.
The results also indicate a key role for HEF1, in that downregulation of this effector molecule with siRNA resulted in significant inhibition of basal and PDGFstimulated migration, as well as a significant inhibition of invasion, whether or not the cells overexpressed FAK. Taken together, these studies suggest that HEF1 acts as an effector signaling molecule of migration and invasion in glioblastoma cells, and functions as such independently of FAK overexpression or PDGF stimulation.
The colocalization of HEF1 with vinculin to focal adhesions in adherent glioblastoma cells and the almost exclusive association of phosphorylated HEF1 with the 0.1% Triton X-100-insoluble cell fraction, in which vinculin is largely found, suggests localization to focal adhesions. As this localization of FAK is known to be necessary for its activation and signaling, these data indicate that the phosphorylated HEF1 is localized appropriately to act as a downstream effector of FAK in these cells. The transient nature of HEF1 phosphorylation in the cells adherent to rec-osteopontin is consistent with the known role of p130CAS in promoting focal adhesion turnover, and the short half-life of focal adhesions (B5 min) (reviewed in Schlaepfer and Mitra, 2004) . Consistent with our previous report of promotion of Rac1 activation on PDGF stimulation of the U-87MG cells adherent to vitronectin under serumstarving conditions , the elevation of Rac1 activity on FAK overexpression, its enhanced elevation on PDGF stimulation, and the inhibition of basal and PDGF-stimulated Rac1 activity on expression of mutant FAK(397F) indicates that Rac1 is the small GTPase effector molecule downstream of FAK and HEF1. In support of Rac1-promoting migration through its effects on membrane protrusion, we found localization of Rac1 to the filopodia and lamellipodia of migrating cells in the scratch assay. The longer time frame of increased Rac1 activity in the cells overexpressing FAK and stimulated with PDGF, as compared to HEF1 phosphorylation, is consistent with the longer time period required for membrane protrusion and promotion of cell migration.
The failure of the expression of the mutant FAK(397F) to completely abolish cell migration is consistent with several reports indicating that dominant interfering forms of FAK do not completely abolish cell migration Haskell et al., 2003) and suggests the possibility that other molecules may promote cell migration in the U-251MG cells. The FAK family member Pyk2 has been reported to promote cell migration or invasion of several cell types (Lipinski et al., 2003; Zrihan-Licht et al., 2004) and CAS family members are thought to act as downstream effectors of Pyk2 as well as of FAK in promoting cell migration . We cannot rule out the possibility that Pyk2 promotes, in part, the basal migration of the U-251MG-derived OFAK5 glioblastoma cells in the absence of FAK overexpression and PDGF stimulation, and that HEF1 could be acting as a downstream effector of Pyk2 in these cells under the basal conditions. However, our data strongly suggest that FAK, rather than Pyk2, promotes the basal migration of these cells under the conditions of our assays, and that FAK predominantly promotes the PDGF-stimulated migration of these cells.
As EGFR expression is frequently increased in glioblastoma tumors (Wong et al., 1987) , we examined whether EGF also promotes migration of the glioblastoma cells adherent to rec-osteopontin. This possibility seems unlikely, however, as EGF stimulation of cells overexpressing FAK did not enhance the migration, and did not enhance the phosphorylation of HEF1; no phosphorylation of p130CAS or Sin/Efs was observed (data not shown). Specific growth factor receptors are known to cooperate with specific integrin receptors in promoting cell migration (ffrench-Constant and Colognato, 2004) , and EGFR is known to cooperate with integrin a5b1, which recognizes fibronectin (Lee and Juliano, 2002) . Integrin avb3 is known to cooperate with the PDGFrb on glioblastoma cells , and integrins avb3 and avb5 largely mediate the migration of these cells when adherent to osteopontin or vitronectin (Ding et al., 2002) . Thus, the PDGFr and EGFR seem to act as complementary, rather than redundant systems, in the promotion of glioblastoma cell migration.
As FAK and HEF1 were found to promote glioblastoma cell invasion through normal brain homogenates, our results demonstrating that HEF1 is a specific and necessary downstream effector of FAK are likely relevant to the in vivo invasion of glioblastoma cells and suggest HEF1 may be an important new target for the development of therapy aimed at treating glioblastoma tumors.
Materials and methods
Reagents
Antibodies were purchased as follows: mAb anti-phosphotyrosine, rabbit anti-Pyk2 IgG, rabbit anti-Sin/Efs IgG (Santa Cruz Biotechnology); mAb anti-vinculin (American Qualex); mAb anti-actin (Sigma Chemical Co.); rabbit anti-p130CAS IgG (Upstate Biotechnology); rabbit anti-integrin av IgG directed toward a cytoplasmic tail peptide (Chemicon Inc.); rabbit anti-FAK IgG (Upstate Biotechnology); and mAb anti-HEF1 (clone 2G9, Immuquest). A rabbit anti-Sin/Efs IgG created by injecting a GST fusion protein (residues 419-561 of the carboxyl terminus) was used for immunoprecipitation (IP) and blotting, PDGF BB (referred to as PDGF) and EGF (R&D Systems) were stored at À701C and thawed once for use. Rec-human osteopontin and purified vitronectin were as described previously (Ding et al., 2002) . Cells U-251MG human glioblastoma cells were obtained from Dr Darell Bigner (Duke University, Durham, NC, USA), and propagated as described (Ding et al., 2002) . U-251MG cells stably expressing wild-type or mutant FAK (397F) in the TETinducible system have been described previously (Wang et al., 2000; Hecker et al., 2004) . U-87MG human glioblastoma cells were obtained from the ATCC and propagated as described . Cells were monitored for mycoplasma contamination using nested PCR (ATCC).
Scratch motility and invasion assays
Cells were harvested with buffered EDTA and plated into 12-well plates (60 000 cells/well) coated previously with 10 mg/ml rec-osteopontin or 5 mg/ml vitronectin. The confluent monolayer were scratched after 24 h, stimulated with PDGF or vehicle (10 min, 371C) and then allowed to migrate for 48 or 72 h, as described previously . The invasion assay was performed as described previously (Ding et al., 2002) .
Immunoblot analysis
This was performed as described previously (Ding et al., 2005) . Fold changes in band intensities were based on densitometric reading of that band from X3 different autorad exposures and the readings averaged.
siRNA studies HEF1 siRNA duplexes targeting the sequence CCAGGA-CATTCGCAACAAA, were synthesized by Dharmacon Inc. For the duplex siRNA, the antisense sequence was dTdTGGU CCUGUAAGCGUUGUUU, and the sense sequence was CCAGGACAUUCGCAACAAAdTdT. p130CAS, FAK, and Pyk2 siRNA duplexes were purchased from Santa Cruz Biotechnology, and were a pool of duplex siRNA. Lamin A/C siRNA duplexes and a nonspecific control siRNA duplex were purchased from Dharmacon Inc. Transient transfection of siRNA was carried out using LipofectAMINE 2000 (Invitrogen), according to the manufacturer's guidelines.
Differential solubilization
Serum-starved (48 h) cells were harvested with buffered EDTA and plated onto rec-osteopontin-coated flasks in DMEM media with 0.4% FBS and 1% BSA, for 3 h (371C, 5% CO 2 ) then stimulated with PDGF (332 pM, 3 or 10 min) or vehicle. After solubilization in 0.1% Triton X-100 in PBS with 0.2 mM PMSF, 1 mg/ml leupeptin, 1 mg/ml aprotinin, 0.2 mM Na vanadate, 10 mM N-ethylmaleimide, and 5 mM benzamidine for 10 min at 41C, the soluble fraction was aspirated and 2 Â RIPA lysis buffer added (10 min, 41C). The insoluble fraction was solubilized with RIPA lysis buffer with protease inhibitors (10 min, 41C). The lysates were clarified by centrifugation (35 000 r.p.m., 1 h, 41C), the protein concentration was assayed, and 300 mg immunoprecipitated with the indicated antibodies overnight (41C). The immunoprecipitates washed 3 Â with PTO buffer and 3 Â with PT buffer, subjected to disulfide-reduced 7.5% SDS-PAGE, and immunoblotted with the indicated antibodies.
Immunofluorescence This was performed as described .
Rac1 activity assay
This was performed as per the instructions in the kit from Upstate Biotechnology, and as described . The GTP-bound form of Rac1 was pulled-down with a PAK kinase-binding domain glutathione fusion protein coupled to agarose.
Statistical analysis
A Wilcoxon's rank-sum test was used for all statistical analyses with a significance level of 0.05.
Abbreviations
CAS, crk-associated substrate; Efs, embryonic Fyn substrate; EGF, epidermal growth factor; EGFR, EGF receptor; FAK, focal adhesion kinase; HEF1, human enhancer of filamentation 1; IP, immunoprecipitation; PDGF, platelet-derived growth factor BB; PDGFr, PDGF receptor; rec, recombinant; si, small interfering; Sin, Src-interacting protein.
